NCT03234309View on ClinicalTrials.gov

Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 20, 2017

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Brain Neoplasm
Interventions
DRUG

Ferumoxytol

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER